NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1043327620 M.D.
Verify on CMS → Michael Fanucchi, M.D.
Medical Oncology Physician in Hawthorne, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
280
Medicare Part D claims · 49 beneficiaries · Medical Oncology Physician avg: 689
MIPS score
86/100
▲ 2 pts above national avg 83.5 · Above neutral
What the federal data shows
Michael Fanucchi, M.D. reported a CMS MIPS final score of 86/100 - above the 83.5 national average - and filed 280 Medicare Part D claims in 2023.
- 86/100
- MIPS score · +2 vs avg
- 280
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥46th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Fanucchi, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
86 ≥ 46th percentile 46% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Fanucchi, M.D. sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Fanucchi, M.D. writes more Part D claims than 37% of them and scores higher on MIPS quality than 45% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Michael Fanucchi, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Fanucchi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Fanucchi, M.D.?
High performer (top quartile)Primary specialty
Medical Oncology Physician
Medicare Part D claims
280 59% vs specialty avg
MIPS final score
86/100 2.5 pts vs avg
Specialty distribution in New York
How Medical Oncology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Michael Fanucchi, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 86/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Fanucchi, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 19 BRADHURST AVE STE 2300N, Hawthorne, NY, 10532, with a listed phone of (914) 909-9018. NPI 1043327620 was issued on 08/23/2006.
Medicare Part D records for calendar year 2023 show 280 prescription claims written by this provider, covering 49 Medicare beneficiaries and totaling roughly $284K in drug spend, with an opioid prescribing rate of 6.8%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86/100 for the 2023 performance year (Quality 83.2, Cost 70.1), compared with the 83.5 average among clinicians with a measured score.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1043327620 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/23/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
85.992
Final Score
Measured-score avg: 83.5
83.1837
Quality
70.123
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Michael Fanucchi, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mary Imogene Bassett Hospital
Cooperstown, NY
Our Lady OF Lourdes Memorial Hospital Inc
Binghamton, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Michael Fanucchi, M.D.. To verify Michael Fanucchi, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
280
Total Claims
$284K
Total Drug Cost
49
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 290
- Total Day Supply
- 7,894
- Generic Drug Cost
- $175K
- Opioid Claims
- 19 (6.8% rate)
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 78.3 years
- Avg HCC Risk Score
- 2.06
- Gender Split
- 27% female / 73% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Fanucchi, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Warfarin Sodium
Warfarin Sodium
49 claims
- Atorvastatin Calcium
Atorvastatin Calcium
21 claims
- Calcitriol 16
Calcitriol
16 claims
- Colchicine 12
Colchicine
12 claims
- Losartan Potassium 12
Losartan Potassium
12 claims
- Montelukast Sodium 12
Montelukast Sodium
12 claims
- Dexamethasone 11
Dexamethasone
11 claims
- Imatinib Mesylate 11
Imatinib Mesylate
11 claims
| Drug | Claims |
|---|---|
| Warfarin Sodium | 49 |
| Atorvastatin Calcium | 21 |
| Calcitriol | 16 |
| Colchicine | 12 |
| Losartan Potassium | 12 |
| Montelukast Sodium | 12 |
| Dexamethasone | 11 |
| Imatinib Mesylate | 11 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 11 |
| Tamsulosin Hcl | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Michael Fanucchi, M.D. fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Michael Fanucchi, M.D.'s 280 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Fanucchi.
One of 395 Medical Oncology Physician providers enrolled in New York, 5 are shown here.
Dr. Ghassan Abou-Alfa
MD
New York, NY
Nour Abuhadra
New York, NY
Melissa Accordino
New York, NY
Dr. David Aggen
M.D., PH.D.
New York, NY
Dr. Carol Aghajanian
MD
New York, NY
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Michael Fanucchi, M.D.'s specialty? ▼
Michael Fanucchi, M.D. specializes in Medical Oncology Physician and practices in Hawthorne, New York. Credentials: M.D..
How much does Michael Fanucchi, M.D. prescribe under Medicare Part D? ▼
In 2023, Michael Fanucchi, M.D. wrote 280 Medicare Part D claims totaling $284K in drug costs for 49 beneficiaries.
What is Michael Fanucchi, M.D.'s Medicare quality score? ▼
Michael Fanucchi, M.D. has a CMS MIPS Final Score of 86/100 (Quality: 83.2, Cost: 70.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Fanucchi, M.D. located? ▼
Michael Fanucchi, M.D. is located at 19 BRADHURST AVE STE 2300N, Hawthorne, NY, 10532. Phone: (914) 909-9018.
What is Michael Fanucchi, M.D.'s NPI number? ▼
Michael Fanucchi, M.D.'s National Provider Identifier (NPI) is 1043327620, issued on 08/23/2006.
Does Michael Fanucchi, M.D. prescribe opioids? ▼
Yes, Michael Fanucchi, M.D. had 19 opioid claims in 2023 with an opioid prescribing rate of 6.8%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Michael Fanucchi, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Fanucchi, M.D.'s most frequently prescribed drugs include Warfarin Sodium, Atorvastatin Calcium, Calcitriol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Fanucchi, M.D. accept Medicare? ▼
Michael Fanucchi, M.D. appears in CMS Medicare data with 280 Part D claims and 49 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Fanucchi, M.D.'s credentials? ▼
Michael Fanucchi, M.D.'s NPI is 1043327620 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.